Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-22

Clinical Trial Update: The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Qishenyiqi Drop Pills for improving prognosis in heart failure patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qishenyiqi Drop Pills

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN